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Aim: We aimed to isolate and characterize the cell types which could be obtained from postnatal extra-embryonic tissues. Materi-
als and Methods: Fresh tissues (no more than 12 h after delivery) were used for enzymatic or explants methods of cell isolation. 
Obtained cultures were further maintained at 5% oxygen. At P3 cell phenotype was assessed by fluorescence-activated cell sort-
ing, population doubling time was calculated and the multilineage differentiation assay was performed. Results: We have isolated 
multiple cell types from postnatal tissues. Namely, placental mesenchymal stromal cells from placenta chorionic disc, chorionic 
membrane mesenchymal stromal cells (ChM-MSC) from free chorionic membrane, umbilical cord MSC (UC-MSC) from whole 
umbilical cord, human umbilical vein endothelial cells (HUVEC) from umbilical vein, amniotic epithelial cells (AEC) and amni-
otic MSC (AMSC) from amniotic membrane. All isolated cell types displayed high proliferation rate together with the typical 
MSC phenotype: CD73+CD90+CD105+CD146+CD166+CD34-CD45-HLA-DR-. HUVEC constitutively expressed key markers 
CD31 and CD309. Most MSC and AEC were capable of osteogenic and adipogenic differentiation. Conclusion: We have shown 
that a wide variety of cell types can be easily isolated from extra-embryonic tissues and expanded ex vivo for regenerative medicine 
applications. These cells possess typical MSC properties and can be considered an alternative for adult MSC obtained from bone 
marrow or fat, especially for allogeneic use.
Key Words: amniotic epithelial cells, amniotic mesenchymal stromal cells, chorionic membrane mesenchymal stromal cells, placental 
mesenchymal stromal cells, umbilical cord mesenchymal stromal cells, human umbilical vein endothelial cells.
Extra-embryonic tissues are composed of the 
placenta, fetal membranes, and umbilical cord. The 
placenta is a disc with a diameter of 15–20 cm and 
a thickness of 2–3 cm. The fetal membranes, amnion 
and chorion, extend from the edges of the chorionic 
disc and enclose the amniotic fluid and the fetus. Pla-
centa, amnion and umbilical cord are usually discarded 
after childbirth whereas they are a reserve of a variety 
of cell types. During last years these postnatal extra-
embryonic tissues have attracted much attention 
as a valuable source of stem cells to be used in medi-
cine as they are readily available, and their potential 
use for cell therapy poses no ethical issues. Moreover, 
due to their early embryonic origin, extra-embryo stem 
cells have more plasticity comparing to adult stem cells 
and additionally possess immunomodulatory poten-
tial (as a part of fetomaternal tolerance mechanism), 
which allows their safe use even in allogeneic applica-
tions [1]. Thus we were interested in characterization 
and comparison of the maximal quantity of cell types 
which could be isolated from term extra-embryo tis-
sues.
MATERIALS AND METHODS
Our experiments were done in accordance with 
the bioethics and biological safety norms confirmed 
by the Medical company ilaya® Bioethics Commis-
sion permission. All donors have signed an informed 
consent before tissue donation.
Cell isolation and culturing. Fresh afterbirth 
(less than 12 h after delivery) was disassembled 
to different tissue types and washed several times 
in HBSS (Sigma-Aldrich, USA) with 1 g/l streptomycin, 
1000,000 IU/l penicillin and 2.5 mg/ml amphotericin B 
(Sigma-Aldrich, USA). Mesenchymal stromal cells 
(MSC) of different origin were isolated by explants 
method or via enzymatic digestion. Respective tissues 
were minced and digested in a mix of 0.1% pronase 
and 0.1% collagenase type II in DMEM/F12 medium 
supplemented with 2% FBS (all from Sigma-Aldrich, 
USA) for 1 h at +37 °C. The reaction mix was then di-
luted 5× with PBS (Sigma-Aldrich, USA) and the cells 
were pelleted at 800 g 10 min at +4 °C. Afterwards the 
cells were resuspended in growth medium (α-MEM 
supplemented with 10% FBS, 1 ng/ml bFGF (all from 
Sigma-Aldrich, USA), 200 μM stable L-glutamine, 
1× antibiotic-antimycotic solution (all from BioWest, 
France) and further cultured at +37 °C, 5% O2 and 5% 
CO2 in a multigas incubator (Binder CB 210, Germany).
Human umbilical vein endothelial cells (HUVEC) 
were obtained by a brief digestion of the inner wall 
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of umbilical vein by 0.1% collagenase type II in DMEM/
F12 medium (Sigma-Aldrich, USA). The cells were 
further cultured on collagen-coated dishes in EGM-
2 medium (Lonza, USA) at +37 °C, 5% O2 and 5% 
CO2 in a multigas incubator (Binder CB 210, Germany).
Amniotic epithelial cells (AEC) were isolated 
as described by Miki et al. [2]. Briefly, the amnion 
was separated from the chorion, extensively washed 
in PBS (Sigma-Aldrich, USA) until no blood clots re-
mained. Then the tissue was briefly washed in PBS 
with 0.53 mM Na2EDTA and digested twice in 0.05% 
trypsin in 0.53 mM Na2EDTA (Sigma-Aldrich, USA) for 
40 min at +37 °C. Each time the reaction was stopped 
with double volume of α-MEM supplemented with 10% 
FBS (Sigma-Aldrich, USA). The cells were pelleted 
at 400 g 10 min at +4 °C. The cell viability was assessed 
by Trypan Blue staining (Sigma-Aldrich, USA). Then 
up to 105 cells/cm2 were seeded on collagen-coated 
dishes. The cells were cultured in DMEM/F12 me-
dium supplemented with 10% FBS, 10 ng/ml EGF, 
1 ng/ml bFGF, 1× sodium pyruvate, 100 μM isoproter-
enol (all from Sigma-Aldrich, USA), 200 μM stable L-
glutamine, 1× antibiotic-antimycotic (all from BioWest, 
France) at +37 °C, 5% O2 and 5% CO2 in a multigas 
incubator (Binder CB 210, Germany).
Amniotic MSC (AMSC) were isolated by explants 
method from the remains of amniotic membrane 
trypsin digestion.
The cells were subcultured when they reached about 
90% confluency. 0.05% trypsin in 0.53 mM Na2EDTA 
(Sigma Aldrich, USA) was used for cell dissociation.
The population doubling time (PDT) was calculated 
using the online source: http://www.doubling-time.com/ 
compute.php [3].
Flow cytometry. The cell phenotype was as-
sessed by fluorescence-activated cell sorting (FACS) 
on the BD FACSAria flow cytometer (BD Pharmin-
gen, BD Horizon, USA). Staining with the monoclo-
nal antibodies (PerCP-Cy5.5 mouse anti-human 
CD105, APC mouse anti-human CD73, FITC mouse 
anti-human CD90, PE-Cy5 mouse anti-human HLA-
DR, PE-Cy7 mouse anti-human CD31, APC mouse 
anti-human CD34, FITC mouse anti-human CD45, 
PE-CF592 mouse anti-human CD146, BV421 mouse 
anti-human CD166, PF mouse anti-human CD309) was 
performed according to the manufacturer’s instruc-
tions (BD Pharmingen, BD Horizon, USA).
Directed multilineage differentiation. Adipo-
genic and osteogenic differentiation were performed 
as described previously [4]. Briefly, adipogenic differ-
entiation was performed in DMEM with high glucose 
content (4.5 g/l) (Sigma-Aldrich, USA) supplemented 
with 5% horse serum (BioWest, France), 10% FBS, 
1 μM dexamethasone, 200 μM indomethacine, 
500 μM isobutylmethylxanthine and 5 μg/ml insulin (all 
from Sigma-Aldrich, USA). After 14 days the cells were 
fixed and stained with Oil Red O (Sigma-Aldrich, USA).
Osteogenic differentiation was performed in DMEM 
with low glucose content (1 g/l) with 10% FBS, 
100 nM dexamethasone, 10 mM b-glycerophosphate 
and 50 μg/ml ascorbate-2-phosphate (all from Sigma-
Aldrich, USA). After 14 or 21 days the cells were fixed and 
stained with BCIP/NBT Liquid Substrate System or Aliza-
rin Red S respectively (all from Sigma-Aldrich, USA).
RESULTS AND DISCUSSION
Extra-embryonic tissues-derived cells pos-
sess MSC phenotype. Overall we obtained seven cell 
culture types from extra-embryonic tissues. We used 
enzymatic digestion to isolate cells from placenta 
(further referred as placental mesenchymal stromal 
cells — Pl-MSC), from free chorionic membrane 
(ChM-MSC), from amniotic membrane (AEC), two cell 
types from umbilical cord (MSC isolated by enzymatic 
digestion — UC-MSC enz. and HUVEC). Two more 
cell types were obtained by explants method: from 
amniotic membrane (AMSC) and from umbilical cord 
(UC-MSC expl.). The cells phenotype was assessed 
by FACS at P3. All described cell types demonstrated 
high level of MSC markers expression, e.g. CD73, 
CD90, CD105, CD146, CD166 (except HUVEC which 
did not express CD90); and did not express markers 
of hematopoietic progenitor cells, e.g. CD34, CD45, 
HLA-DR (Table, Fig. 1). HUVEC additionally expressed 
key markers CD31 and CD309. Interestingly, AEC 
maintained the same level of MSC markers expression 
until P8 (data not shown).
PDT and morphology of extra-embryonic 
tissues-derived cells. Along with the phenotype 
analysis we calculated the PDT at P1–P3 for all de-
scribed cell lines. The average PDT for most cell lines 
was about 30 h (Fig. 2). However, AEC and UC-MSC 
enz. doubled their number in less than 24 h, whereas 
the PDT for HUVEC was about 60 h. On the whole, 
extra-embryonic tissues-derived cell lines demon-
strated high proliferation potential with stable PDT for 
at least three passages.
As expected, HUVEC had epitheloid morphology, 
whereas all other cell lines demonstrated typical for 
MSC fibroblastoid morphology (Fig. 3, a–f). Interest-
Table. Flow cytometry results of surface antigen expression on extra-embryonic tissues-derived cells. Data presented as a percentage of parent popula-
tion
Cell culture Surface antigen expression,%CD73 CD90 CD105 CD146 CD166 CD31 CD309 CD34 CD45 HLA-DR
AEC 98.5 99.4 81.2 89.0 84.2 N/D N/D 0.3 0.3 0.9
AMSC 98.1 99.2 89.6 94.2 84.5 N/D N/D 0.3 0.2 0.7
ChM-MSC 97.7 98.7 97.6 98.0 94.0 N/D N/D 0.9 0.3 0.9
Pl-MSC 97.1 97.6 97.3 94.9 93.2 N/D N/D 2.2 1.3 2.7
UC-MSC enz. 96.5 99.7 96.0 98.6 96.5 N/D N/D 0.4 0.4 1.0
UC-MSC expl. 98.9 99.9 90.6 99.8 98.0 N/D N/D 1.4 0.3 0.6
HUVEC 93.5 2.8 97.6 97.8 92.5 99.8 98.2 1.5 0.1 2.8
Note: N/D — not determined.
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ingly, AEC, initially possessing typical epitheloid mor-
phology, progressively acquired fibroblastoid appear-
ance at P2–P3 (Fig. 3, g) probably due to the EMT [5].
Multilineage differentiation of extra-embry-
onic tissues-derived cells. Next, we performed 
adipogenic and osteogenic differentiation to assess 
cell plasticity of all MSC cell lines and AEC. All de-
scribed cell types successfully underwent adipogenic 
differentiation. However, it was atypical (comparing to 
“classic” bone marrow MSC [6]) as there was plenty 
of tiny lipid vacuoles instead of several big vesicles 
(Fig. 4, a–f). Also AEC and most MSC cells were ca-
Fig. 1. Representative FACS graphics (for HUVEC)
Fig. 2. PDT of extra-embryonic tissues-derived cells
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Fig. 3. Morphology of extra-embryonic tissues-derived cells. The photos are taken at P1. Phase-contrast microscopy. The bar = 
200 μm. a — AMSC; b — ChM-MSC; c — Pl-MSC; d — UC-MSC enz.; e — UC-MSC expl.; f — HUVEC; g — epithelial-to-mesenchymal 
change of AEC morphology in culture. The passages are indicated in image corners
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pable of osteogenic differentiation (assessed by alka-
line phosphatase activity at early stages or by Alizarin 
Red S staining at final stages). The only exceptions 
were the Pl-MSC and UC-MSC enz. that failed typical 
osteogenic differentiation. Instead Pl-MSC formed 
spheres. Surprisingly, UC-MSC isolated via explants 
qualitatively demonstrated osteogenic differentiation. 
However, previous studies demonstrate that UC-MSC 
osteogenic differentiation is quite problematic and 
depends on multiple factors, e.g. culture conditions 
and even which UC segment they are isolated from [7, 
8]. Probably, isolation via explants favors UC-MSC 
capability of mesenchymal lineage differentiation.
Thus obtained MSC cultures fulfill mostly all minimal 
MSC criteria [6], e.g. adherence to plastic, expression 
of typical MSC markers (CD73+,CD90+,CD105+ and 
others) and multilineage differentiation. Moreover, they 
demonstrate high and stable proliferation rate thereby 
allowing obtaining a therapeutic dose in a short time. 
Their usage is not restricted by any ethical issues, and 
due to their immunophenotype (CD34-CD45-HLA-DR-) 
they could be safely used for allogeneic applications. 
Two special cell types are of particular interest as they 
have unique properties: HUVEC and AEC. HUVEC 
as effective angiogenic progenitors may be used for 
regeneration of vessels or vascularization of complex 
organ transplants as well as for separate applications 
for correction of the tissue ischemic consequences 
[9]. As for AEC, they originate from embryonic epiblast, 
thereby capable of generating cells from all three germ 
Fig. 4. Multilineage differentiation of extra-embryonic tissues-derived cells. (a–f) Adipogenic differentiation. Red Oil O and Ro-
manowsky stains. Phase-contrast microscopy. The bar = 50 μm. a — AEC; b — AMSC; c — ChM-MSC; d — Pl-MSC; e — UC-MSC 
enz.; f — UC-MSC expl. (g–i) Osteogenic differentiation. BCIP/NBT stain. Light microscopy. The bar = 100 μm. g — AEC; h — ChM-
MSC; i — Pl-MSC. (j–l) Osteogenic differentiation. Alizarin Red S stain. Phase-contrast microscopy. The bar = 100 μm. j — AMSC; 
k — UC-MSC enz.; l — UC-MSC expl.
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layers (ectoderm, mesoderm and endoderm) [10]. This 
is of particular interest as it potentially permits liver and 
pancreas restoration. Moreover, several successive 
animal stu dies have already been performed in those 
directions [11, 12]. These outstanding features together 
with high accessibility make multiple cell types isolated 
from extra-embryonic tissues an attractive substrate for 
regenerative medicine applications.
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